Showing 1 post by Neil Ganulin.
As a result of huge costs and pricing pressures, many drug development players are now participating in public-private partnerships (PPP) to share the costs of drug development efforts. Read More ›
Ask the Blogger
Do you have a topic that you would like discussed in a future blog article? Please let us know. If you have a confidential question regarding a blog article, please feel free to contact the article's author directly, or let us know if you would like for someone to contact you directly.
Thomas D. Anthony is the former chair of FBT's Health Care Industry Team. He focuses on counseling health care entities on corporate transactions, regulatory compliance and joint ventures.